Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label previous answer version answering member constituency answering member printed answering member label
tabling member	label

Search

1140530

registered interest
date	19/07/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Preventive Medicine
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, if he will publish the prevention Green Paper before the summer recess.
tabling member constituency	Scunthorpe
tabling member printed	Nic Dakin
uin	279415
answer	answer is ministerial correction date of answer 24/07/2019 answer text <p>The Green Paper ‘Advancing our health: prevention in the 2020s’ was published on 22 July 2019.</p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 24/07/2019 06:37:56 answering member 4455 label Biography information for Seema Kennedy
tabling member	4056 label Biography information for Nic Dakin

1140582

registered interest
date	19/07/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	NHS: Drugs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, when he plans to issue guidance to health professionals on the Serious Shortage Protocol.
tabling member constituency	North Norfolk
tabling member printed	Norman Lamb
uin	279389
answer	answer is ministerial correction date of answer 26/07/2019 answer text <p>A Serious Shortage Protocol is an additional tool to manage serious medication shortages and may be used in the exceptional and rare situation when other measures have been exhausted or are likely to be ineffective.</p><p>At present we are currently working on the governance process for developing Serious Shortage Protocols, should one be required, through engagement, including with professional bodies and patient groups. Following this we will issue guidance to health professionals in due course.</p><p>The Pharmaceutical Services Negotiating Committee, the organisation who represent National Health Service community pharmacy contractors in England, have developed a briefing note to support community pharmacies, who will need to consider training and changes to their standard operating-procedures to take account of the potential new processes.</p><p>Any Serious Shortage Protocol would be developed by senior, specialist doctors and pharmacists, with input from national experts, Royal Colleges and specialist societies. If a Serious Shortage Protocol is to be authorised then there will also be engagement with the relevant patient groups, who can assist in informing patients. Pharmacists still have to use their professional judgment as to whether supplying against the protocol rather than the prescription is appropriate and provide the patient with relevant information. If they determine supply is not appropriate, then the patient should be referred back to their prescriber.</p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 26/07/2019 11:34:54 answering member 4455 label Biography information for Seema Kennedy previous answer version 131086 answering member constituency South Ribble answering member printed Seema Kennedy answering member 4455 label Biography information for Seema Kennedy
tabling member	1439 label Biography information for Norman Lamb

1140170

registered interest
date	18/07/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Heart Diseases and Strokes: Females
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, if he will respond to the recommendations in the report entitled Call for Action: Inquiry into heart attack and stroke, published by the all-party Parliamentary group on women’s health in July 2019; and if he will make a statement.
tabling member constituency	Dewsbury
tabling member printed	Paula Sherriff
uin	279083
answer	answer is ministerial correction date of answer 23/07/2019 answer text <p>NHS England has acknowledged the recently published report and will be considering the content.</p><p>Improving the prevention and treatment of heart attacks and stroke are key aims in the NHS Long Term Plan, with an important milestone being for the National Health Service to help prevent up to 150,000 heart attacks, strokes and dementia cases over the next 10 years. The NHS Long Term Plan highlights that outcomes from heart attack and stroke can be improved, and that there should be a focus on inequalities.</p><p><strong> </strong></p><p><strong> </strong></p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 23/07/2019 16:54:04 answering member 4455 label Biography information for Seema Kennedy
tabling member	4426 label Biography information for Paula Sherriff

1140171

registered interest
date	18/07/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Heart Diseases and Strokes: Females
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps his Department is taking to improve (a) outcomes, (b) early identification and (c) treatment of heart attack and stroke for women.
tabling member constituency	Dewsbury
tabling member printed	Paula Sherriff
uin	279084
answer	answer is ministerial correction date of answer 23/07/2019 answer text <p>Improving the prevention and treatment of heart attacks and stroke are key aims in the NHS Long Term Plan, with an important milestone being for the National Health Service to help prevent up to 150,000 heart attacks, strokes and dementia cases over the next 10 years. The NHS Long Term Plan highlights that outcomes from heart attack and stroke can be improved, and that there should be a focus on inequalities.</p><p>In addition, addressing variations in outcomes from cardiovascular disease (CVD), such as heart attacks and stroke, is one of Public Health England’s (PHE) top priorities, and in February 2019, PHE announced new 10-year CVD ambitions for England, which are intended to complement the NHS Long Term Plan and are the first ever national ambitions to improve the detection and treatment of the major causes of CVD.</p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 23/07/2019 16:48:22 answering member 4455 label Biography information for Seema Kennedy
tabling member	4426 label Biography information for Paula Sherriff

1140209

registered interest
date	18/07/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Cystic Fibrosis: Drugs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what recent discussions there have been between Vertex Pharmaceuticals and NHS England with on cystic fibrosis medicines.
tabling member constituency	Bristol East
tabling member printed	Kerry McCarthy
uin	278928
answer	answer is ministerial correction date of answer 23/07/2019 answer text <p>Discussions with Vertex, including meetings, are ongoing.</p><p>NHS England and NHS Improvement are leading the negotiations with Vertex and have made a revised and improved offer to Vertex that would provide immediate funding for Orkambi and Symkevi in advance of a positive assessment by the National Institute for Health and Care Excellence (NICE), in addition to expanded access to Kalydeco which is already funded by the National Health Service for certain patients.</p><p>The Government fully supports NICE, NHS England and NHS Improvement in seeking to ensure access for patients to effective and innovative medicines at a price that represents value to the NHS, and it is not for Ministers to intervene in this process. The Department’s approach remains to strongly urge Vertex to accept NHS England’s and NHS Improvement’s generous offer, but in the absence of a deal, we have asked NHS England and NHS Improvement to continue to explore all options to ensure patients can access treatments as soon as possible.</p> answering member constituency South Ribble answering member printed Seema Kennedy grouped question UIN 278929 question first answered 23/07/2019 16:49:59 answering member 4455 label Biography information for Seema Kennedy
tabling member	1491 label Biography information for Kerry McCarthy

1140210

registered interest
date	18/07/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Cystic Fibrosis: Drugs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, if he will set a deadline for NHS England and Vertex Pharmaceuticals to come to an agreement to enable access to cystic fibrosis medicines produced by that company.
tabling member constituency	Bristol East
tabling member printed	Kerry McCarthy
uin	278929
answer	answer is ministerial correction date of answer 23/07/2019 answer text <p>Discussions with Vertex, including meetings, are ongoing.</p><p>NHS England and NHS Improvement are leading the negotiations with Vertex and have made a revised and improved offer to Vertex that would provide immediate funding for Orkambi and Symkevi in advance of a positive assessment by the National Institute for Health and Care Excellence (NICE), in addition to expanded access to Kalydeco which is already funded by the National Health Service for certain patients.</p><p>The Government fully supports NICE, NHS England and NHS Improvement in seeking to ensure access for patients to effective and innovative medicines at a price that represents value to the NHS, and it is not for Ministers to intervene in this process. The Department’s approach remains to strongly urge Vertex to accept NHS England’s and NHS Improvement’s generous offer, but in the absence of a deal, we have asked NHS England and NHS Improvement to continue to explore all options to ensure patients can access treatments as soon as possible.</p> answering member constituency South Ribble answering member printed Seema Kennedy grouped question UIN 278928 question first answered 23/07/2019 16:49:59 answering member 4455 label Biography information for Seema Kennedy
tabling member	1491 label Biography information for Kerry McCarthy

1140227

registered interest
date	18/07/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	5G: Health Hazards
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what research his Department has conducted on the potential effect on public health of upgrading infrastructure to support 5G.
tabling member constituency	Streatham
tabling member printed	Chuka Umunna
uin	279011
answer	answer is ministerial correction date of answer 23/07/2019 answer text <p>Public Health England (PHE) advises that the guidelines of the International Commission on Non-Ionizing Radiation Protection (ICNIRP) should be adopted and there is no convincing evidence that radio wave exposures below the ICNIRP guideline levels cause adverse health effects. The ICNIRP guidelines cover exposures arising from new 5G base stations, as well as from older technologies.</p><p>Many exposure measurements have been made at publicly accessible locations near to mobile phone base stations, and these have consistently been well within guidelines. It is possible that there may be a small increase in overall exposure to radio waves when 5G is added to an existing network or in a new area; however, the overall exposure is expected to remain low relative to guidelines and as such there should be no consequences for public health.</p><p> </p><p>PHE has published information about exposure to the radio waves from mobile phone base stations, including those for 5G networks, at the following link:</p><p> </p><p><a href="https://www.gov.uk/government/publications/mobile-phone-base-stations-radio-waves-and-health/mobile-phone-base-stations-radio-waves-and-health" target="_blank">https://www.gov.uk/government/publications/mobile-phone-base-stations-radio-waves-and-health/mobile-phone-base-stations-radio-waves-and-health</a></p><p> </p><p>PHE continues to monitor the health-related evidence applicable to radio waves and is committed to updating its advice as required.</p><p><strong> </strong></p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 23/07/2019 16:52:28 answering member 4455 label Biography information for Seema Kennedy
tabling member	4128 label Biography information for Chuka Umunna

1140237

registered interest
date	18/07/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	HIV Infection: Drugs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 12 July 2019 to Question 273310 on HIV Infection: Drugs, whether work has started on future commissioning of PrEP; and which individuals will be involved in that work.
tabling member constituency	Exeter
tabling member printed	Mr Ben Bradshaw
uin	278896
answer	answer is ministerial correction date of answer 26/07/2019 answer text <p>Officials are working with NHS England and Public Health England to consider long-term commissioning options and a further statement will be made in due course.</p> answering member constituency South Ribble answering member printed Seema Kennedy grouped question UIN 278897 278898 278899 question first answered 26/07/2019 11:29:10 answering member 4455 label Biography information for Seema Kennedy
tabling member	230 label Biography information for Mr Ben Bradshaw

1140238

registered interest
date	18/07/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	HIV Infection: Drugs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 12 July 2019 to Question 273310 on HIV Infection: Drugs, if he will take steps to ensure that all commissioning routes are considered before April 2020 so that the patients currently on the impact trial do not face a hard end to the treatment in September 2020.
tabling member constituency	Exeter
tabling member printed	Mr Ben Bradshaw
uin	278897
answer	answer is ministerial correction date of answer 26/07/2019 answer text <p>Officials are working with NHS England and Public Health England to consider long-term commissioning options and a further statement will be made in due course.</p> answering member constituency South Ribble answering member printed Seema Kennedy grouped question UIN 278896 278898 278899 question first answered 26/07/2019 11:29:10 answering member 4455 label Biography information for Seema Kennedy
tabling member	230 label Biography information for Mr Ben Bradshaw

1140239

registered interest
date	18/07/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	HIV Infection: Drugs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 12 July 2019 to Question 273310 on HIV Infection: Drugs, if he will take steps to ensure that commissioning routes are established before September 2020.
tabling member constituency	Exeter
tabling member printed	Mr Ben Bradshaw
uin	278898
answer	answer is ministerial correction date of answer 26/07/2019 answer text <p>Officials are working with NHS England and Public Health England to consider long-term commissioning options and a further statement will be made in due course.</p> answering member constituency South Ribble answering member printed Seema Kennedy grouped question UIN 278896 278897 278899 question first answered 26/07/2019 11:29:10 answering member 4455 label Biography information for Seema Kennedy
tabling member	230 label Biography information for Mr Ben Bradshaw